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 Abstract 
Background: This prospective study aimed to compare dose volume histograms (DVH) 
of the breasts and organs at risk (OARs) of whole breast radiotherapy in the supine and 
prone positions, and frequency and severity of acute and late toxicities were analyzed. 
Methods: Early-stage breast cancer patients with large breasts (Japanese bra size C or 
larger, or the widest measurements of the bust ≥ 95 cm) undergoing partial mastectomy 
participated in this study. CT-based treatment plans were made in each position, and 
various dosimetric parameters for the breast and OARs were calculated to compare the 
supine and prone radiotherapy plans. The actual treatment was delivered in the position 
regarded as better. Results: From 2009 to 2010, 22 patients were prospectively accrued. 
Median follow-up period was 58 months. The homogeneity index and lung doses were 
significantly lower in the prone position (P=0.008, P < 0.0001 and P < 0.0001, 
respectively). Cardiac dose showed no significant differences between 2 positions. By 
comparing 2 plans, the prone position was chosen in 77% of the patients. In the prone 
position, ≥ grade 2 acute dermatitis were seen in 47% of patients treated, whereas 20% 
of the patients treated in the supine position had grade 2 and no cases of grade 3, 
although without a statistical significance of the rates of ≥ grade 2 acute dermatitis 
between the 2 positions (P =0.28). The actual dose measurement using a breast phantom 
revealed significantly higher surface dose of the breast treated in the prone position than 
 that in the supine position. Conclusions: Breast irradiation in the prone position 
improves PTV homogeneity and lowers doses to the OARs in the Japanese large-breast 
patients. However meticulous positioning of the breast in the prone board avoiding the 
bolus effect is necessary to prevent acute dermatitis. 
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 Background 
 
Adjuvant whole breast radiotherapy (WBRT) after partial mastectomy for breast 
cancer is a gold standard. However, adjuvant WBRT may have technical difficulties in 
women with large breasts when treated in the supine position. Several institutions have 
shown increased radiation toxicities and worse cosmetic outcomes for patients with 
large, pendulous breasts and/or increased body mass index [1-4]. A previous study from 
our institution reported that the incidence of ≥ grade 2 acute dermatitis for the patients 
with large-volume breasts treated with WBRT were higher than for the other patients 
although without a statistical significance (15% vs 7%, p=0.214) [5] In addition, 
patients with large breasts may receive increased doses to critical structures such as the 
heart or the lungs owing to the breast positioning when the patients are treated in the 
supine position. WBRT in the prone position aims to overcome some of the technical 
limitations associated with treating large, pendulous breasts and/or large body habitus, 
and it may also reduce radiation doses to the organs at risk (OARs) [6-11]. 
Many reports of the prone WBRT have been published from the United States and 
Europe, but rarely from Japan. It is because the incidence of obesity in Japan is much 
lower than in the western countries and the number of Japanese patients with large 
breasts is small who would gain much benefit from WBRT in the prone position. 
 However, in recent years, because of the changing dietary habits, breast size of Japanese 
women has become larger. In 1980 only 16.2% of Japanese women had breasts of 
Japanese C cup brassiere or larger, in comparison to 62% in 2004 [12] , and the number 
of patients with large breasts is expected to increase further in the future, therefore an 
assessment of safety and efficacy of adjuvant prone WBRT in Japan deems to be 
necessary and important. 
In this prospective study, we compared dose volume histograms (DVHs) of the 
breasts and OARs (heart and lung) in the supine and prone positions, and delivered 
actual treatment in the position which was regarded as better with respect to DVH. 
Furthermore, we investigated frequency and severity of acute radiation dermatitis and 
late toxicities in all the patients. Additionally, the difference in the surface doses 
between the two positions was analyzed by an actual dose measurement using a breast 
phantom. 
 
Methods 
 
Patient eligibility 
The patients with stage 0-II (Tis-T2, N0-1) breast cancer and large or pendulous 
 breasts (Japanese bra size C or larger, or the widest measurements of the bust equal to 
or over 95 cm) undergoing partial mastectomy in National Cancer Center Hospital were 
eligible for this prospective study. Exclusion criteria were history of irradiation to the 
ipsilateral breast, concurrent malignancy, and active connective tissue disorders. The 
patients with positive axillary nodes were required to undergo axillary lymph nodes 
dissection. Patients with 4 or more axillary lymph node metastasis were not eligible 
because the supraclavicular region was also irradiated routinely in ≥ 4 node-positive 
patients in our institution. 
This prospective study was approved by the Institutional Review Board of the 
National Cancer Center (reference number: 21-15), and all enrolled patients gave their 
written informed consents before being registered in the study. Written informed 
consents for publication and presentation of individual clinical data had been obtained 
from all the participants. 
 
Simulation and target definition 
Each patient underwent 2 CT simulations (AquilionTM, Toshiba, Tokyo, Japan) in the 
supine and prone positions. Patients were first imaged (3-mm CT slice thickness) in the 
supine position with both arms over the head. The borders of the breast fields were 
 marked using radioopaque wires. Patients were then reimaged in the prone position on a 
specially designed prone board (ALL-IN-ONE patient positioning system, ORFIT, 
Wijnegem, Belgium) that allowed the indexed breast tissue to fall freely below the table 
(Fig.1). 
 
Fig. 1. A patient lying on the prone board. 
Patients were simulated in the prone position in a prone board (ALL-IN-ONE patient positioning 
system, ORFIT, Wijnegem, Belgium) allowing the breast tissue to fall freely below the table. 
 
Target and OARs (bilateral lungs and heart) were delineated on each CT slice in both 
positions. The clinical target volume (CTV) was defined as the entire ipsilateral 
palpable breast tissue, where the wires served as an aid to define the borders of the 
 CTV. The CTV was assumed to start 5 mm below the skin. Postoperative cavity and all 
the clips placed during operation to show the cavity margins were included in the CTV. 
An isotropic 7 mm margin was added to the CTV to obtain the planning target volume 
(PTV). For evaluating the dose of the PTV, PTV_EVAL was generated from the PTV, 
excluding the lung and 2 mm thick tissue under the skin.  
 
Treatment planning 
For each patient, opposing tangential fields with 4 MV photons were setup to 
irradiate PTV in both supine and prone positions. Physical wedge filters were used 
when the maximum dose of PTV exceeded 115% of the prescribed dose. A field-in-
field technique was not allowed in this study because the breast shape in the prone 
position was not as reproducible as supine position. Beam edges of lung side were 
matched accordingly to reduce the lung dose. Radiation fields did not exceed the 
midline and did not include the contralateral breast. The dose prescribed to the ICRU 
prescription point was 50 Gy in 25 fractions. Beam data of 4 MV X-ray from a linear 
accelerator (Clinac iX, Varian, Palo Alto, CA, USA) was used for calculation of DVHs 
by Eclipse treatment planning system (Varian Medical Systems, Palo Alto, CA, USA). 
Fig. 2 shows typical dose distributions of a patient with pendulous breasts in the prone 
 and supine positions. Following dose parameters were calculated by using algorithm of 
the Analytical Anisotropic Algorithm (AAA) [13-15] with a heterogeneity correction: 
the minimum coverage dose of 5% or 95% of the PTV_EVAL (D5%, D95%), mean doses 
in the PTV_EVAL (Dmean), bilateral lung volume irradiated equal to or over 20 Gy (lung 
V20), mean lung dose of the bilateral lungs (MLD), and mean heart dose. In an attempt 
to analyze dose homogeneity within the PTV_EVAL, homogeneity index (HI: D5%/ 
D95%) was calculated for both positions. 
 
Fig. 2. Typical dose distributions of a patients with a pendulous breast. 
For each patient, opposing tangential fields were setup to irradiate PTV in both supine and prone 
positions. 
 
 In 9 patients, boost irradiation of 10 Gy in 5 fractions by an electron beam was 
performed due to close margins, as defined at our institution as being < 5mm. The 
electron irradiation was done in the supine position. In this study, the dose from electron 
irradiation was not taken into account. 
 
Selection of the better treatment position 
DVHs of both positions were compared and the actual treatment was delivered in the 
position which was regarded as better with regard to DVH. The better treatment 
position could provide (1) better heart and lung sparing, and (2) improved dose 
homogeneity in PTV_EVAL, and it was determined by discussion of two radiation 
oncologists. In cases where the two radiation oncologists judged no DVH parameter 
differences in both positions, the supine position was chosen for the treatment because 
the supine position was more reproducible than the prone position. 
 
Study endpoints and statistical analysis 
Primary endpoints of this study were the frequency and severity of acute radiation 
toxicities. In our institution, incidence of the acute morbidities including acute 
dermatitis > grade 2 among the patients with large breast treated with supine WBRT 
 was considered to be around 20% [5]. Therefore, threshold incidence of the acute 
dermatitis > grade 2 in the prone WBRT was assumed as 20%, and the expected 
incidence as 7%. With the type one error rate of 5% and 80% power, 40 patients must be 
allocated to the prone WBRT, so the study will continue until 40 patients end up 
receiving prone WBRT.  
Secondary endpoints were the comparison of PTV_EVAL dose homogeneity, doses 
to the OARs, and incidence of the late toxicities. The grade of acute dermatitis was 
classified according to the CTCAE, version 3 [16]. Acute dermatitis was graded by the 
worst toxicity occurring until 3 months after completion of the WBRT. Acute dermatitis 
was evaluated in the skin out of electron boost field. Late toxicity was assessed by 
LENT/SOMA [17]. Late toxicity was graded by worst toxicity from 4th month after 
WBRT to the last follow-up visit. Cosmetic outcome was physician-assessed at the last 
follow-up according to the Harvard Scale [18]. 
Statistical analyses were done using a two-sided paired t-test for continuous variables 
and chi-square test for categorical variables. For all statistical tests a significance level 
of 0.05 was used. 
 
Surface dose measurement of the breast phantom 
 In this study, incidence of > grade 2 acute dermatitis in the prone WBRT was higher 
than estimated. Therefore, we performed an actual dose measurement using breast 
phantom in order to evaluate the skin dose. A single right breast phantom attached to the 
thorax phantom (Model 002LFC, CIRS, Virginia, USA) was used for the dose 
measurement. Thirty-five pieces of 2 cm x 2 cm cut-outs from a radiochromic film 
(EBT3, International Speciality Product, New Jersey, USA) were uniformly attached 
onto surface of the right breast phantom. After irradiation of 200 cGy using tangential 
fields with 4 MV X-rays, the 35 pieces of radiochromic film cut-outs were digitized 
with an ES-8500 flatbed scanner (SEIKO-EPSON, Nagano, Japan) under a resolution of 
72 dpi. Absolute dose were derived from the optical density using a conversion table. 
Mean absolute dose was determined from measured values of 4 spots in the cut-out. 
Dosimetry was performed in 3 breast phantom positions: the prone position where the 
breast phantom was located in the center of the prone board (“prone center position”), 
the prone position where the breast phantom was located at the medial and cranial side 
of the prone board (“prone medial and cranial position”) and the supine position (Fig. 
3). 
  
Fig. 3. Two prone breast phantom positions. 
(a) The prone position where the breast phantom was located in the center of the prone board (“prone 
center position”). (b) The prone position where the breast phantom was located at the medial and 
cranial side of the prone board (“prone medial and cranial position”). 
 
 Results 
 
Patient characteristics 
Between September 2009 and May 2010, 22 patients with breast cancer undergoing 
partial mastectomy were prospectively accrued to this trial (13 right-sided: 9 left-sided). 
Because of the unexpectedly high incidence of the acute dermatitis > grade 2 in the 
prone WBRT, this trial was terminated after 17 patients underwent prone WBRT. Table 
1 summarizes baseline characteristics of the 22 patients. Median age was 50 years 
(range: 35-74 years). More than half of the patients reported their bra cup-size as C. 
Five patients (23%) with the tumor ≥ 3 cm or with positive lymph nodes received 
neoadjuvant chemotherapy. All 3 patients (14%) with 1-3 lymph nodes metastases 
underwent axillary lymph nodes dissection and received adjuvant or neoadjuvant 
chemotherapy. No patients had 4 or more lymph nodes metastases, therefore radiation 
fields including the axillary or the supraclavicular region were not used in this study. All 
patients completed the prescribed course of external beam radiotherapy. None of the 
patients required a treatment break due to acute toxicity. Median follow-up length was 
58 months (range: 20 months to 64 months). 
 
 Table 1. Characteristics of 22 patients in the study 
    
Breast Right   13 (59%) 
 Left  9 (41%) 
    
Age (years) Median (Range) 50 (35-74) 
    
ECOG PS 0   22 (100%) 
    
Self-reported Japanese bra cup-
size 
B  2 (9%) 
C  12 (55%) 
 D  4 (18%) 
 E  2 (9%) 
 F  2 (9%) 
    
Stage 0  4 (18%) 
 IA  7 (32%) 
 IIA (T2N0)  8 (36%) 
 IIB(T2N1)  2 (9%) 
 IIIA(T3N1)  1 (5%) 
    
Tumor size (cm) Median (Range) 2.2 (0.6-5.1) 
    
Neoadjuvant chemotherapy Yes  5 (23%) 
 No  17 (77%) 
    
WBRT dose (50 Gy)   22 (100%) 
    
Boost radiation (10Gy) Yes  9 (41%) 
   prone (n=17)   6 (35%) 
   supine (n=5)   3 (60%) 
 No  13 (59%) 
     
Follow-up (months) Median (Range) 58 (20-64) 
        
    
ECOG: Eastern Cooperative Oncology Group 
PS: performance status    
WBRT: whole breast radiotherapy 
 
Treatment-related toxicities and cosmetic results 
The prone position was chosen in 17 (77%) patients and the supine position was 
chosen in 5 (23%) patients for WBRT as described below in detail. Acute dermatitis of 
the patients treated in the prone position was grade 1 in 9/17 (53%), grade 2 in 7/17 
(41%), and grade 3 in 1/17 (6%). For patients treated in the supine position, there were 
no cases of grade 3 dermatitis, while 4/5 (80%) had grade 1, 1/5 (20%) had grade 2 
(Table 2). There were no cases of acute dermatitis > grade 4 in both treatment groups. 
Incidence of ≥ grade 2 acute dermatitis was higher in the prone position although 
without a statistical significance (P =0.28). The most frequent late toxicity was 
pigmentation, which occurred in 35% of patients treated in the prone position and 20% 
in the supine position. Severity of the late toxicities were limited to grade 1 or 2 in all 
the patients. No patients experienced breast fibrosis or breast retraction. There were no 
cases of symptomatic radiation pneumonitis or significant cardiac events during the 
 follow-up period in both treatment groups. 
Table 2. Acute dermatitis, late toxicity and physician-assessed 
cosmesis in the prone and supine positions 
    
toxicity prone (n=17) supine (n=5) 
acute dermatitis     
Grade1 9 (53%) 4(80%) 
Grade2 7 (41%) 1 (20%) 
Grade3 1 (6%) 0 
   
late toxicity   
Pigmentation   
Grade1 5 (29%) 1 (20%) 
Grade2 1 (6%) 0 
Fibrosis   
Grade1 0 0 
Grade2 0 0 
Retraction   
Grade1 0 0 
Grade2 0 0 
Telangiectasia   
Grade1 1 (6%) 0 
Grade2 0 0 
Edema   
Grade1 2 (12%) 1 (20%) 
Grade2 0 0 
   
cosmesis   
Execellent/Good 16 (94%) 5 (100%) 
Fair 1 (6%) 0 
Poor 0 0 
      
 
 On the basis of the Harvard Scale for cosmetic outcomes, the majority of patients 
(94% in the prone position, and 100% in the supine position) had good or excellent 
cosmetic outcomes (Table 2). Only 1 patient treated in the prone position had a fair 
cosmetic outcome (6%). 
 
DVH analysis 
CT-based treatment plans were made in 2 treatment positions (supine/prone) and the 
DVHs of PTV_EVAL and OARs (lung, heart) were compared. In the prone position, 
D5% was significantly lower (P=0.004) and D95% was significantly higher (P=0.01) than 
in the supine position, but Dmean and the volume of PTV_EVAL were not different 
between the 2 positions (Dmean: P=0.53, the volume of PTV_EVAL: P=0.74). The 
homogeneity index was significantly lower for the prone position (mean 1.16) than for 
the supine (mean 1.27) (P=0.008) (Table 3). 
Table 3. Volumes and dosimetric values of PTV_EVAL and OARs in the prone and 
supine positions 
    
  Prone Supine   
  mean±SD p 
    
PTV_EVAL    
    
 PTV_EVAL volume (cm3) 629±252 636±247 0.74 
    
D5% (Gy) 52.3±0.8 53±1 0.004 
    
D95% (Gy) 45.2±1.4 42.3±4.8 0.01 
    
Dmean (Gy) 48.9±1.8 48.6±1.5 0.53 
    
HI 1.16±0.04 1.27±0.19 0.008 
    
OARs    
    
Lung V20 (%) 0.8±0.8 4.6±1.7 <0.0001 
    
Mean lung dose (Gy) 1.4±0.6 3.6±0.8 <0.0001 
    
Mean heart dose (Gy) (n = 9) 3.1±1.6 3.0±0.9 0.9 
        
    
HI: homogeneity index (D5%/D95%)   
OARs: organs at risk    
PTV_EVAL: planning target volume for evaluation   
 
The prone position afforded a greater sparing of the lung. Mean lung V20 and MLD 
were lower in the prone position with a statistical significance (lung V20: P < 0.0001, 
MLD: P < 0.0001) (Table 3). Cardiac dose was evaluated in the 9 patients with left-
sided cancers; there were no significant differences between the 2 positions (P =0.9) 
(Table 3). 
  
Treatment position 
By comparing 2 treatment plans, the prone position was chosen in 17 (77%) patients, 
because it spared the lung better in 17/17 (100%), homogeneity or coverage of 
PTV_EVAL were better in 7/17(41%), or heart dose was lower in 2/17 (12%). In the 
remaining 5 (23%) patients, the supine position was chosen for the treatment, because it 
enabled better heart exclusion from the fields in 1/5 (20%) and PTV_EVAL 
homogeneity was better in 1/5 (20%). In the patients with no differences of dose 
parameters in both positions (3/5; 60%), the supine position was chosen for the 
treatment. 
 
Treatment efficacy 
During the follow-up, no locoregional recurrence occurred among the 22 patients. 
Three patients developed distant failures; one of these patients expired, and 2 are 
currently alive with disease. 
 
Surface dose measurement of the breast phantom 
We found unexpectedly that the patients treated in the prone position had a higher 
 tendency to develop acute dermatitis in the medial part of the ipsilateral breast (Fig. 4). 
We hypothesized that the unusual distribution of acute dermatitis could be explained by 
a bolus effect of the prone board. To validate the hypothesis, we performed an actual 
dose measurement using a breast phantom and the prone board.  
 
Fig. 4. Acute dermatitis in the medial part of the irradiated breast. 
We found unexpectedly that the patients treated in the prone position had a higher tendency to 
develop acute dermatitis in the medial part of the ipsilateral breast. 
 
Dose measurement was performed in the 3 breast phantom positions as described 
 above. Because the breast phantom was not large or pendulous, the “prone medial and 
cranial position” was supposed to reproduce the situation that the large or pendulous 
breast was pressed into the edge of the prone board.  
The surface dose of the breast phantom was significantly higher in both prone 
positions than in the supine position. (“prone center position” vs supine position: 
P=0.01, “prone medial and cranial position” vs supine position: P<0.0001) (Table 4). 
Furthermore, surface dose of the breast phantom was significantly higher in the “prone 
medial and cranial position” than that in the “prone center position” (P=0.0007). Fig. 5 
shows a higher surface dose in medial and cranial part of the right breast phantom 
treated in the “prone medial and cranial position”. This part corresponds approximately 
to the pressed breast area to the prone board and this dose distribution might be 
consistent with the unusual distribution of acute dermatitis in the prone WBRT. 
Table 4. Surface doses of the breast phantom        
             
position mean±SD (range) (cGy) p        
             
prone center position* 145.3±16.7 (105.2-176.1) 
 
 
 
       
  0.0007        
prone medial and cranial position** 163.8±18.2 (121.3-210.5)  0.01       
  <0.0001        
supine 136.7±17.4 (108.2-167.2)         
              
          
prone center position*: Prone position where the breast phantom was located  
in the center of the prone board 
   
          
prone medial and cranial position**: Prone position where the breast phantom was located 
at the medial and cranial side of the prone board  
 
 
Fig. 5. Color map showing the dose of each film cut-out piece.  
(a) “Prone center position”. (b) “Prone medial and cranial position”. (c) Supine position. Medial 
breast surface in the “prone medial and cranial positreferenion” was irradiated to the highest dose. 
 
Discussion 
 
 Dose inhomogeneity of tangential WBRT has been implicated in the occurrence of 
poor cosmetic outcomes and late toxicities in the patients undergoing partial 
mastectomy and postoperative WBRT. Several authors have published data 
demonstrating that the prone position for WBRT improves dose homogeneity of the 
irradiated breast and limits the dose to the OARs (Table 5). However, this study is the 
first prospective trial delivering actual postoperative radiotherapy in the position which 
was regarded as better than the other after comparing dose parameters both in the prone 
and supine positions.  
Table 5. Comparison of published series of prone position for breast radiotherapy 
      
References Year n Study objectives Inclusion criteria Observated results 
Merchant et 
al.[10] 
1994 56 Prone whole breast 
iradiation 
Breast irradiation Improve dose homogeneity of 
the breast 
Grann et al. 
[19] 
2000 56 Prone whole breast 
iradiation 
Large or 
pendulous breast 
Improve dose homogeneity of 
the breast. 
80% of patients experienced 
Grade I or Grade II erythema. 
Mahe et al. 
[20] 
2002 35 Prone whole breast 
iradiation 
Large and/or 
pendulous breast 
The high-dose regions of the 
base 
and the top of the breast did 
not exceed 105%. Only G1-2 
acute dermatitis was 
observed. 
Griem et al. 
[8] 
2003 15 Planning comparison 
prone vs. supine 
Breast irradiation Improve dose homogeneity 
with the prone position. 
Significant improve lung 
 DVH, no differences for 
heart. 
Formenti et 
al.  [7] 
2004 50 Partial breast 
irradiation in prone 
Postmenopausal 
T1N0 
Good lung and heart DVH 
Buijsen et al. 
[6] 
2007 10 Planning comparison 
prone vs. supine 
Pendulous 
breasts (bra 
sizeD and over) 
Improve dose homogeneity 
and lung DVH with the prone 
position 
Stegman et al. 
[29] 
2007 245 Prone whole breast 
iradiation 
Beams with 
gantry angles of 
90°±10°and 
270°±10° 
Grade 2-3 acute dermatitis 
were limited to 18%. 
Grade 2, Grade 3, and Grade 
4 chronic dermatitis was seen 
in 27.8%, 2.8%, and 1.6%. 
Varga et al.  
[11] 
2009 61 Planning comparison 
prone vs. supine 
Breast irradiation Significant improve lung 
DVH, no differences for 
heart. 
Kirby et al.  
[24] 
2010 65 Planning comparison 
prone vs. supine 
Partial or total 
breast irradiation 
Improve lung DVH; improve 
heart DVH for big breast 
Bergom et al.  
[21] 
2012 110 Prone whole breast 
iradiation 
Large body 
habitus and/or 
large-pendulous 
breasts 
Excellent to good cosmesis 
was achieved in 89%. G3 
acute dermatitis in 5%. 
Lymberis et 
al. [25] 
2012 100 Planning comparison 
prone vs. supine 
(3DCRT or IMRT) 
Breast irradiation  Improve lung and heart DVH 
with the prone position 
Formenti et 
al.  [26] 
2012 200 Planning comparison 
prone vs. supine 
Breast irradiation  Reduction in the amount of 
irradiated lung in all patients 
and in the amount of heart 
volume irradiated in 85% of 
patients with left breast 
cancer. 
Mulliez et al.  
[22] 
2013 100 Comparing prone 
and supine setup of 
hypo-fractionated 
IMRT 
European cup 
size C or more 
Improve dose coverage, better 
homogeneity, less volumes of 
over-dosage with the prone 
position 
      
 DVH: dose volume histograms   
      
3DCRT: Three-dimensional conformal radiation therapy 
      
IMRT: Intensity Modulated Radiation Therapy 
 
In this study, we could demonstrate improvement of the dose homogeneity in the 
prone position for large breasted patients. Reports from larger series have indicated the 
same trend as this study [8, 10]. The benefit was more evident in patients with very 
large or pendulous breasts, or deformities of the chest cavity [6, 19, 20]. Our criteria of 
large breast was different from the ones previously reported from the western countries. 
Japanese bra size is different from the US size. For example, most Japanese C cup 
corresponds to US B cup. The breast volumes of our patients were smaller than that of 
the patients enrolled in the western studies where mean breast volumes were more than 
1000 cm3 [21, 22], while the mean breast volume of our patients was 629 cm3 (range 
230-1074 cm3). Even if the breast size was not as large as the ample bust of women in 
the US or Europe, improvement of the dose homogeneity was demonstrated in the 
PTV_EVAL by using prone position. 
One of the serious problems in treatment of the large breasts is the larger lung 
volumes irradiated due to the steep gantry angles needed to obtain an adequate coverage 
of breast tissue. Even in the smaller breasts in our study, lung V20 and MLD, an 
 indicator for radiation-induced lung damage, showed significantly lower values in the 
prone position as compared to the supine position. This was in accordance with other 
studies that analyzed lung dose in the prone breast irradiation [6, 7].  
As shown by the large study of Darby et al. [23], larger incidental dose to the heart 
increased the risk of ischemic heart disease especially in women with preexisting 
cardiac risk factors. Although we could evaluate cardiac dose of only 9 patients with 
left-sided cancers, there were no significant differences between the 2 positions. The 
dose to the heart is generally not higher in the prone as compared to the supine WBRT 
[8, 11, 24, 25]. Formenti et al. [26] reported that the prone position was associated with 
a reduction of in-field heart volume compared with the supine position, but the 
reduction reached a statistical significance only in the women with breast size > 750 
cm3. Probably because of the small number and the small breast volume of our patients, 
difference of the cardiac doses might not be statistically significant between the two 
positions. However, the dose to the coronary arteries, left ventricle or the anterior 
compartment might increase due to displacement of the heart anteriorly in the prone 
position [27]. Optimal sparing of coronary arteries by contouring of left anterior 
descending branch is recommended if patients are treated with the prone WBRT [28]. 
Despite improved dose homogeneity and DVHs of OARs in the prone position, we 
 found the patients actually treated in the prone position developed severer dermatitis 
than we had expected. In our study, 47% of patients treated in the prone position 
experienced grade 2-3 acute dermatitis. In contrary, results of the previous studies have 
indicated that the proportion of patients with severe acute dermatitis was small even 
when treated in the prone position [19-21, 29]. By measuring actual dose using a breast 
phantom, we could indicate the surface dose of the breast where it is pressed to the 
prone board was higher than other areas of the breast. It was due to the bolus effect of 
prone board, because high dose to the cranial medial side of the phantom was not seen 
in the irradiation in the “prone center position”, where surface of the breast phantom 
was not pressed to the prone board. We also demonstrated a slightly higher surface dose 
of the breast treated in the “prone center position” compared to the supine position with 
a statistical significant difference. The “prone center position” is corresponding to the 
setup using prone board. Because the difference of the setups between the “prone center 
position” and supine position was presence or absence of the prone board, we assumed 
that the bolus effect of the prone board occurred even though it was not abutted the 
breasts in the “prone center position”. We routinely use 4 MV photons when setting up 
tangential radiation fields of the breast because the small breasts are common in Japan, 
and accordingly we used 4 MV photons in this study. Meanwhile, more than 6 MV 
 photons are usually used for setup to irradiate large breasts in US and Europe. The bolus 
effect is typically more apparent when using 4 MV photons than using over 6 MV 
photons, therefore in this study, higher surface dose of breast phantom was clearly 
demonstrated and severer dermatitis with an unusual distribution was observed, which 
differed from the toxicity results of the previous studies. We recommend that breast 
surface, especially of the cranial and medial side, should not be attached and pressed to 
the prone board in case of the prone WBRT and 6 MV or higher energy photon should 
be used to treat patients with large or pendulous breast. 
Fig.6 shows the setup image, digitally reconstructed radiography (DRR) and 
verification portography of the patient shown in the Fig. 4, and the setup position of this 
patient seemed to be acceptable. In our institution, the verification portography was 
taken only once on the first day of WBRT due to an abundance of breast cancer 
patients. The prone position is not as reproducible as the supine position and sometimes 
difficult to set up even using markers of body surface. In order to reduce interfractional 
positioning difference, verification portography should be monitored more frequently 
when the patient is treated in the prone position than in the supine position.  
  
Fig. 6. Prone setup of the patient shown in the Fig. 4.  
(a) The setup image. (b) Digitally reconstructed radiography (DRR). (c) Verification portography. 
 
Incidence of non-serious late toxicities and cosmetic results were not different 
between the prone and supine positions.  
The major limitation of this study is that the number of enrolled patients was small; 
this was because the population of patients with large breasts was unexpectedly small, 
and we experienced relatively unexpected acute dermatitis among the patients treated in 
the prone position during registration. We performed axillary lymph node dissection on 
all node-positive patients and they didn’t receive regional nodal irradiation. Since 
MA.20 [30] and EORTC 22922/10925 [31] were reported, the trend in treatment for 1-3 
node-positive patients have been an addition of irradiation to the supraclavicular nodes 
and parasternal nodes. Additionally, the results from ACOSOG Z0011 [32] and 
AMAROS [33] indicated the omission of axillary lymph nodes dissection had a low 
impact on the local recurrence or prognosis when appropriate cases were selected and 
 adequate adjuvant therapy including regional nodal irradiation were performed. The 
present study was conducted before the results of studies described above were 
available, thus the patients who might have to receive regional nodal irradiation were 
treated without regional irradiation. However, all the patients with positive nodes in our 
study underwent axillary lymph nodes dissection and adjuvant or neoadjuvant 
chemotherapy, and no recurrence of regional lymph nodes were observed during follow-
up. 
The strengths of our study include that toxicity and cosmesis were scored 
prospectively, and the median follow-up length of 58 months was sufficiently long to 
take into account the latency of radiation toxicities. The breast surface dose was 
measured using breast phantom resulting in the confirmation that the surface dose was 
higher treated in the prone position than treated in the supine position. With a 
meticulous positioning of the breast in the prone board, an appropriate choice of photon 
energy according to the size of the breast, and verification portography with a 
reasonable frequency, acute dermatitis can be prevented and prone WBRT will be a 
preferred technique to improve PTV_EVAL homogeneity and OAR doses in a large 
breast.  
 
 Conclusions 
 
WBRT for Japanese large-breasted women in the prone position will improve 
PTV_EVAL homogeneity and OAR doses. However if a prone board is used, a 
meticulous positioning of the breast, an appropriate choice of photon energy and 
verification portography of setup with a reasonable frequency is necessary to prevent 
severe acute dermatitis. 
 
 
List of abbreviations 
DVH: dose volume histograms; OAR: organ at risk; WBRT: whole breast radiotherapy; 
CTV: clinical target volume; PTV: planning target volume; PTV_EVAL: planning target 
volume for evaluation; AAA: Analytical Anisotropic Algorithm; D5%: minimum 
coverage dose of 5% of PTV_EVAL; D95%: minimum coverage dose of 95% of 
PTV_EVAL; Dmean: mean doses in the PTV_EVAL; lung V20; bilateral lung volume 
irradiated equal to or over 20 Gy; MLD: mean lung dose of bilateral lungs; HI: 
homogeneity index 
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